Patricia L. Novak

Corporate Officer/Principal at

University of California, Irvine

Health Technology

Commercial Services

Consumer Services

Profile

Patricia L.
Novak is Vice President of Program Development for Cardium Therapeutics, Inc., which she joined in November 2005.
She was Executive Director of Program Management and R&D for Metabasis Therapeutics and Vice President of Program Management for Collateral Therapeutics from 2000 to 2003 and Senior Director of Program Management from 1997 to 2000.
From 1991 to 1997, Dr. Novak was Director of Research and Development Planning and Project Management for Gensia, Inc. and Clinical Project Manager of Alpha Therapeutic Corporation from 1987 to 1991.
She received a PhD in Biological Sciences from the University of California, Irvine.

Patricia L. Novak active positions

Companies	Position	Start
University of California, Irvine University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Patricia L. Novak

Former positions of Patricia L. Novak

Companies	Position	End
Cardium Therapeutics, Inc. /Old/ Cardium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops therapeutics and treatments for coronary artery disease and heart attacks	Corporate Officer/Principal	2006-01-22
Collateral Therapeutics, Inc. Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products	Corporate Officer/Principal	2002-12-31
SICOR, Inc. SICOR, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Corporate Officer/Principal	1996-12-31
Alpha Therapeutic Corp. Alpha Therapeutic Corp. BiotechnologyHealth Technology Develops of plasma derived products	Corporate Officer/Principal	1990-12-31
Taxus Cardium Pharmaceuticals Group, Inc. Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease	Corporate Officer/Principal	-

See the detail of Patricia L. Novak's experience

Training of Patricia L. Novak

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patricia L. Novak's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Collateral Therapeutics, Inc. Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products	Commercial Services
SICOR, Inc. SICOR, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
Metabasis Therapeutics, Inc. Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs	Health Technology
Cardium Therapeutics, Inc. /Old/ Cardium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops therapeutics and treatments for coronary artery disease and heart attacks	Commercial Services
Alpha Therapeutic Corp. Alpha Therapeutic Corp. BiotechnologyHealth Technology Develops of plasma derived products	Health Technology
University of California, Irvine University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Taxus Cardium Pharmaceuticals Group, Inc. Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease	Health Technology